HAUPPAUGE, NY (Nov. 30, 2020) – COVAXX, a U.S. company developing a synthetic multitope peptide-based vaccine to fight COVID-19, today announced that Chief Scientific Officer Farshad Guirakhoo, Ph.D. will participate in the Opening Keynote panel discussion, “SARS-CoV-2 - We ha...